Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, December 1999, p. 2885-2892, Vol. 43, No. 12
Rega Institute for Medical Research, K. U. Leuven, B-3000 Leuven, Belgium
Received 24 March 1999/Returned for modification 16 June
1999/Accepted 20 September 1999
Hydroxyurea has been shown to potentiate the anti-human
immunodeficiency virus activities of
2',3'-dideoxynucleoside analogs such as didanosine. We have
now evaluated in vitro the effect of hydroxyurea on the
antiherpesvirus activities of several nucleoside analogs
(acyclovir [ACV], ganciclovir [GCV], penciclovir [PCV], lobucavir [LBV],
(R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine [H2G],
and brivudin and nucleoside phosphonate analogs (cidofovir [CDV] and adefovir [ADV]). When evaluated in cytopathic effect (CPE) reduction assays, hydroxyurea by itself had little effect on CPE
progression and potentiated in a subsynergistic (herpes simplex virus
type 1 [HSV-1]) to synergistic (HSV-2) fashion the antiviral
activities of ACV, GCV, PCV, LBV, H2G, ADV, and CDV. Hydroxyurea also
caused marked increases in the activities of ACV, GCV, PCV, LBV, and
H2G (compounds that depend for their activation on a virus-encoded
thymidine kinase [TK]) against TK-deficient (TK
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Hydroxyurea Potentiates the Antiherpesvirus Activities of Purine
and Pyrimidine Nucleoside and Nucleoside Phosphonate Analogs
) HSV-1.
In fact, in combination with hydroxyurea the 50% effective concentrations of these compounds for inhibition of TK
HSV-1-induced CPE decreased from values of 20 to
100 µg/ml (in the
absence of hydroxyurea) to values of 1 to 5 µg/ml (in the presence of
hydroxyurea at 25 to 100 µg/ml). When evaluated in a single-cycle
virus yield reduction assay, hydroxyurea at a concentration of 100 µg/ml inhibited progeny virus production by 60 to 90% but had little
effect on virus yield at a concentration of 25 µg/ml. Under these
assay conditions hydroxyurea still elicited a marked potentiating
effect on the antiherpesvirus activities of GCV and CDV, but this
effect was less pronounced than that in the CPE reduction assay. It is
conceivable that the potentiating effect of hydroxyurea stems from a
depletion of the intracellular deoxynucleoside triphosphate pools, thus
favoring the triphosphates of the nucleoside analogues (or the
diphosphates of the nucleoside phosphonate analogues) in their
competition with the natural nucleotides at the viral DNA polymerase
level. The possible clinical implications of these findings are discussed.
*
Corresponding author. Mailing address: Rega Institute
for Medical Research, Minderbroedersstraat 10, B-3000 Leuven, Belgium. Phone: (32)-16-33.73.53. Fax: (32)-16-33.73.40. E-mail:
johan.neyts{at}rega.kuleuven.ac.be.
This article has been cited by other articles:
Copyright © 2010 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»